Press releases are posted on Independent.com as a free community service.
OAKLAND — Attorney General Rob Bonta today co-led a coalition of 20 attorneys general in issuing a joint statement addressing concerns over a U.S. Food and Drug Administration (FDA) review of mifepristone. This review was referenced by Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Martin Makary in response to a letter from Republican state attorneys general to the FDA calling for restrictions on or withdrawal of mifepristone from the market:
Attorney General Bonta is committed to defending and preserving Californians' access to reproductive healthcare, including their access to mifepristone. Earlier this year, Attorney General Bonta filed a petition with the FDA requesting that it eliminate unnecessary restrictions on the abortion medication mifepristone by removing the Mifepristone Risk Evaluation and Mitigation Strategy Program. In 2024, he took steps to ensure that Californians living in Northern California are able to access the emergency reproductive care to which they are entitled by filing a lawsuit against Providence St. Joseph Hospital in Eureka, California, alleging it violated multiple California laws due to its refusal to provide emergency abortion care to people experiencing obstetric emergencies. Later that year, he announced a first-of-its-kind stipulated judgment that ensures the City of Beverly Hills comes into full compliance with the law and provides a benchmark for local governments to align with state reproductive healthcare laws.
Joining Attorney General Bonta in issuing this statement, which he co-led with the attorneys general of Massachusetts and New York, are the attorneys general of Arizona, Colorado, Connecticut, Delaware, the District of Columbia, Hawaii, Illinois, Maine, Maryland, Michigan, Minnesota, New Jersey, New Mexico, Oregon, Rhode Island, Vermont, and Washington.